• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Microbiol Infect . Predictors of Progression From Moderate to Severe COVID-19: A Retrospective Cohort

tetano

Editor, Senior Moderator
Clin Microbiol Infect


. 2020 Jul 2;S1198-743X(20)30379-7.
doi: 10.1016/j.cmi.2020.06.033. Online ahead of print.
Predictors of Progression From Moderate to Severe COVID-19: A Retrospective Cohort


Biao Cheng[SUP] 1 [/SUP], Jiahao Hu[SUP] 2 [/SUP], Xiuran Zuo[SUP] 3 [/SUP], Jian Chen[SUP] 3 [/SUP], Xiaochao Li[SUP] 4 [/SUP], Yuchen Chen[SUP] 5 [/SUP], Guoliang Yang[SUP] 6 [/SUP], Xiaowu Shi[SUP] 7 [/SUP], Aiping Deng[SUP] 8 [/SUP]



Affiliations
Free PMC article

Abstract

Objective: Most coronavirus disease 2019 (COVID-19) cases were identified as moderate, which is defined as having a fever or dry cough and lung imaging with ground-glass opacities. The risk factors and predictors of prognosis in such cohorts remain uncertain.
Methods: All adult patients with COVID-19 of moderate severity diagnosed using qRT-PCR and hospitalized at the Central Hospital of Wuhan, China, from Jan 1 to Mar 20, 2020 were enrolled in this retrospective study. The main outcomes were progression from moderate to severe or critical condition or death.
Results: Among the 456 enrolled patients with moderate COVID-19, 251/456 (55.0%) had poor prognosis. Multivariate logistic regression analysis identified higher NLR on admission (OR =1.032, 95%CI 1.042-1.230, P = 0.004) and higher CRP on admission (OR =3.017, 95%CI 1.941-4.690, P < 0.001) were associated with increased odds ratios of poor prognosis. The area under the receiver operating characteristic (ROC) curve (AUC) for NLR and CRP in predicting progression to critical condition was 0.77 (95% CI 0.694-0.846, P < 0.001) and 0.84 (95% CI 0.780-0.905, P < 0.001), with a cut-off value of 2.79 and 25.95 mg/l, respectively. The AUC of NLR and CRP in predicting death was 0.81 (95% CI, 0.732-0.878, P < 0.001) and 0.89 (95% CI 0.825-0.946, P < 0.001), with a cut-off value of 3.19 and 33.4 mg/l, respectively.
Conclusions: Higher levels of NLR and CRP at admission were associated with poor prognosis of moderate COVID-19 patients. NLR and CRP were good predictors of progression to critical condition and death.

Keywords: COVID-19; moderate; neutrophil-lymphocyte ratio; predict; prognosis.
 
Back
Top Bottom